Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Topical Corticosteroids Market to Grow by USD 1.08 billion between 2022 to 2027, globally at 4% CAGR - Technavio | ||
By: PR Newswire Association LLC. - 30 Jan 2024 | Back to overview list |
|
NEW YORK, Jan. 30, 2024 /PRNewswire/ -- The topical corticosteroids market is estimated to increase by USD 1.08 billion at a CAGR of 4% with a YOY growth rate of 3.5% from 2023 to 2027, according to a recent market study by Technavio. This report also offers a 5-year historical (2017-2021) data projection of market size, segmentation, and region. Discover some insights on market size before buying the full report -Request a Free sample report Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak. The Bargaining Power of Buyers & Suppliers and the Threat of New Entrants, Rivalry, and Substitutes have also been analyzed and rated as LOW-HIGH. Find Technavio's Exclusive Analysis of Price Sensitivity, Adoption Lifecycle, Customer Purchase Basket, Adoption Rates, and Purchase Criteria
The report also offers information on the criticality of inputs, R&D, CAPEX, technology, and products of 15 companies listed Below - AbbVie Inc., Astellas Pharma Inc., AstraZeneca PLC, Bausch Health Co. Inc., Bayer AG, Cipla Ltd., Dr Reddys Laboratories Ltd., Eli Lilly and Co., Galderma SA, GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., LEO Pharma AS, Merck and Co. Inc., Novartis AG, Perrigo Co. Plc, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc. The report is segmented by End-user (Hospitals, Dermatology clinics, Pharmacies, and Others), Type (Prescription and OTC), and Geography (North America, Europe, Asia, and Rest of World (ROW))
To procure the data - Buy the report! Advancements in drug delivery systems are driving the growth. Recent advancements in drug delivery have addressed limitations in topical corticosteroids by enhancing their absorption and bioavailability while reducing systemic exposure. For instance, nanoparticle-based formulations like liposomes and nano gels have improved delivery to the skin. Other promising systems include microemulsions, solid lipid nanoparticles, and dendrimers, offering targeted delivery and sustained release for enhanced efficacy and patient adherence.
The report is segmented by region North America, Europe, Asia, and the Rest of the World (ROW). An analysis of key leading countries has been included.
For Insights on the market dynamics & segmentations View a Free Sample PDF report Topical Corticosteroids in Dermatology: Applications Topical corticosteroids are pharmaceutical formulations used in dermatology for various skin disorders and inflammatory conditions. They are steroidal medications that act as anti-inflammatory agents, targeting conditions like eczema, psoriasis, and atopic dermatitis. These medications modulate the immune response and are crucial in managing inflammatory skin conditions. They are available as creams and ointments and are prescribed in dermatological treatments. Market trends show a growing demand for prescription dermatology products, including corticosteroid formulations. The pharmaceutical industry focuses on drug development for improved patient care, with market analysis and regulatory compliance being integral to treatment modalities. What are the key data covered in this Topical Corticosteroids Market report?
Technavio's SUBSCRIPTION platform Related Reports The global sarcoidosis therapeutics market size is estimated to grow by USD 72.82 million at a CAGR of 4.94% between 2023 and 2028. The global osteoarthritis therapeutics market size is estimated to grow by USD 3,962.95 at a CAGR of 8.97% between 2022 and 2027. ToC: Executive Summary Market Landscape Market Sizing Historic Sizes Five Forces Analysis Segmentation by End-User Segmentation by Type Segmentation by Geography Customer Landscape Geographic Landscape Drivers, Challenges, & Trends Company Landscape Company Analysis Appendix About US Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging trends and provide actionable insights to help businesses identify opportunities and develop effective strategies to optimize their positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable insights to identify opportunities in existing and potential areas and assess their competitive positions within changing scenarios. Contact View original content to download multimedia:https://www.prnewswire.com/news-releases/topical-corticosteroids-market-to-grow-by-usd-1-08-billion-between-2022-to-2027--globally-at-4-cagr---technavio-302046982.html SOURCE Technavio |
||
|
||
Copyright 2024 PR Newswire Association LLC. | Back to overview list |